Contextual Synthetic Lethality: Exploiting Hypoxia and the DNA Damage Response for Novel Therapeutics

被引:0
|
作者
Bristow, R. G. [1 ,2 ]
机构
[1] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
[2] Univ Toronto, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
引用
收藏
页码:544 / 544
页数:1
相关论文
共 50 条
  • [21] Synthetic lethality in synovial sarcoma: SS18-SSX fusions and DNA damage response (DDR) inhibitors
    Fleuren, Emmy D. G.
    Jones, Sam
    Frankum, Jessica
    Williamson, Chris
    Menon, Malini
    Shipley, Janet
    Ashworth, Alan
    van der Graaf, Winette
    Lord, Christopher J.
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Targeting ATR in DNA damage response and cancer therapeutics
    Fokas, Emmanouil
    Prevo, Remko
    Hammond, Ester M.
    Brunner, Thomas B.
    McKenna, W. Gillies
    Muschel, Ruth J.
    CANCER TREATMENT REVIEWS, 2014, 40 (01) : 109 - 117
  • [23] Strategies for targeting the DNA damage response for cancer therapeutics
    Zhang, Dan
    Wang, Hai-Bo
    Brinkman, Kathryn L.
    Han, Su-Xia
    Xu, Bo
    CHINESE JOURNAL OF CANCER, 2012, 31 (08) : 359 - 363
  • [24] Exploiting the DNA Damage Response for Prostate Cancer Therapy
    Stracker, Travis H.
    Osagie, Oloruntoba I.
    Escorcia, Freddy E.
    Citrin, Deborah E.
    CANCERS, 2024, 16 (01)
  • [25] Targeting the DNA Damage Response Pathway by Combination of ATR and PARP Inhibition Imparts Synthetic Lethality to Cervical Cancer Cells
    Hill, Marlee
    Elayapillai, Sugantha Priya
    Hannafon, Bethany N.
    Moxley, Katherine
    AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (10 S): : S1 - S1
  • [26] Ongoing Spontaneous DNA Damage Creates Synthetic Lethality Targeted By Novel RAD51 Inhibitors in Multiple Myeloma
    Kumar, Subodh
    Gkotzamanidou, Maria
    Talluri, Srikanth
    Day, Melinda
    Neptune, Mychell
    Potluri, Lakshmi B.
    Chakraborty, Chandraditya
    Mills, Kevin
    Shammas, Masood A.
    Munshi, Nikhil C.
    BLOOD, 2019, 134
  • [27] Targeting Histone Epigenetic Modifications and DNA Damage Responses in Synthetic Lethality Strategies in Cancer?
    Lazo, Pedro A.
    CANCERS, 2022, 14 (16)
  • [28] Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
    Zimmer, Yitzhak
    Reinhardt, Hans Christian
    Medova, Michaela
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [29] Targeting resistant hypoxic cells by exploiting the DNA damage response
    Hammond, E.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S83 - S83
  • [30] Targeting Synthetic Lethality in DNA Damage Repair Pathways as an Anti-Cancer Strategy
    Moeller, Benjamin J.
    Arap, Wadih
    Pasqualini, Renata
    CURRENT DRUG TARGETS, 2010, 11 (10) : 1336 - 1340